Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🌏 NMPA

TLX101-Tx News

🌏 NMPA ← All news

NMPA TLX101-Tx coverage for business development, investment, and market access teams

High impact NewsApr 15, 2026

Telix Pharmaceuticals Doses First Patient in Phase 3 Trial of TLX101-Tx for Recurrent Glioblastoma

Oncology - Brain Cancer · 3 min

Dr. Yuki Tanaka

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.